XML 33 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted shares
Restricted stock units
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Restricted shares
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted shares
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Non-controlling interests in consolidated entities
Beginning balances (in shares) at Dec. 31, 2018             238,069,000                
Beginning balances at Dec. 31, 2018 $ 6,124.3           $ 47.6     $ 654.6     $ 5,464.1 $ (42.0)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income 2,131.3                       2,131.3    
Other comprehensive income (loss), net of tax (1.0)                         (1.0)  
Dividends declared (733.6)                       (733.6)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             2,924,000                
Shares issued upon option exercises 148.5           $ 0.6     147.9          
Stock issued, restricted stock award, net of shares withheld for taxes (in shares)               (41,000) 1,245,000            
Stock issued, restricted stock award, net of shares withheld for taxes   $ (5.9) $ (59.3)           $ 0.2   $ (5.9) $ (59.5)      
Forfeiture of restricted awards (in shares)             (10,000)                
Forfeiture of restricted awards 0.0                            
Stock-based compensation expense 206.6                 206.6          
Restricted stock units issued as dividend equivalents 0.0                 0.2     (0.2)    
Common shares repurchased (in shares)             (6,973,000)                
Common shares repurchased (708.8)           $ (1.4)     (289.3)     (418.1)    
Ending balances (in shares) at Dec. 31, 2019             235,214,000                
Ending balances at Dec. 31, 2019 7,102.1           $ 47.0     654.6     6,443.5 (43.0)  
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2018 740.3                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income attributable to redeemable non-controlling interests 117.6                            
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests 0.4                            
Net subscriptions into/ redemption from T. Rowe Price investment products 530.3                            
Net deconsolidations of T. Rowe Price investment products (267.6)                            
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2019 1,121.0                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income 2,372.7                       2,372.7    
Other comprehensive income (loss), net of tax 20.0                         20.0  
Dividends declared (846.1)                       (846.1)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             2,194,000                
Shares issued upon option exercises 96.0           $ 0.5     95.5          
Stock issued, restricted stock award, net of shares withheld for taxes (in shares)               8,000 1,457,000            
Stock issued, restricted stock award, net of shares withheld for taxes   0.0 (91.7)           $ 0.3     (92.0)      
Forfeiture of restricted awards 0.0                            
Stock-based compensation expense 246.2                 246.2          
Restricted stock units issued as dividend equivalents 0.0                 0.3     (0.3)    
Common shares repurchased (in shares)             (10,908,000)                
Common shares repurchased (1,192.2)           $ (2.2)     (250.0)     (940.0)    
Ending balances (in shares) at Dec. 31, 2020             227,965,000                
Ending balances at Dec. 31, 2020 7,707.0     $ 7,707.0     $ 45.6     654.6     7,029.8 (23.0)  
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income attributable to redeemable non-controlling interests 150.6                            
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests 34.9                            
Net subscriptions into/ redemption from T. Rowe Price investment products 563.3                            
Net deconsolidations of T. Rowe Price investment products (308.1)                            
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2020 1,561.7                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income 3,082.9     3,082.9                 3,082.9    
Other comprehensive income (loss), net of tax (3.5)     (3.5)                   (3.5)  
Dividends declared (1,003.5)     (1,003.5)                 (1,003.5)    
Special cash dividend declared ($3.00 per share) $ (699.5)     (699.5)                 (699.5)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares) 1,533,084           1,206,000                
Shares issued upon option exercises $ 47.0     47.0     $ 0.2     46.8          
Stock issued, restricted stock award, net of shares withheld for taxes (in shares)               6,000 1,492,000            
Stock issued, restricted stock award, net of shares withheld for taxes   $ 0.0 (127.7)   $ 0.0 $ (127.7)     $ 0.3     (128.0)      
Forfeiture of restricted awards 0.0     0.0                      
Stock-based compensation expense 274.6     274.6           274.6          
Restricted stock units issued as dividend equivalents (0.1)     (0.1)           0.6     (0.7)    
Common shares repurchased (in shares)             (5,941,000)                
Common shares repurchased (1,136.0)     (1,136.0)     $ (1.2)     (809.4)     (325.4)    
Common shares issued for acquisition (in shares)             4,447,000                
Common shares issued for acquisition     $ 881.5     $ 881.5     $ 0.9     $ 880.6      
Non-controlling interests 248.7                           $ 248.7
Ending balances (in shares) at Dec. 31, 2021             229,175,000                
Ending balances at Dec. 31, 2021 9,271.4     $ 9,022.7     $ 45.8     $ 919.8     $ 8,083.6 $ (26.5) $ 248.7
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income attributable to redeemable non-controlling interests 15.6                            
Other comprehensive income (loss), net of tax, attributable to redeemable non-controlling interests (26.2)                            
Net subscriptions into/ redemption from T. Rowe Price investment products (67.7)                            
Net deconsolidations of T. Rowe Price investment products (501.1)                            
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2021 $ 982.3                            
[1] Accumulated other comprehensive income